Results per Page:
RR tracks: a new way to measure viral transmission
From the Bedford Lab, Vaccine and Infectious Disease, Public Health and Human Biology Divisions
Viral kinetics modeling for the current SARS-CoV-2 landscape
From the Schiffer Group, Vaccine and Infectious Disease Division
Researching herpes treatments with 'skin-on-chip' technology
Experimental device grows human skin, infects and treats it; could advance disease modeling in labs
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Few variants arise from acute SARS-CoV-2 infections
From the University of Wisconsin-Madison and the Fred Hutch Vaccine and Infectious Disease Division
Tissue localization shapes antiviral T cell dynamics
From the Prlic and Lund labs, Vaccine and Infectious Disease Division
Snow days may save lives during flu season
From the Seattle Flu Study, Kaiser Permanente, and the Vaccine and Infectious Disease Division
Vaccines stop COVID-19 symptoms, but do they stop transmission?
Researchers mull options, including college dorm studies and 'human challenge' trials, to find answer
Computer model offers insights on COVID-19 super-spreading
New research compares transmission patterns of SARS-CoV-2 with those of influenza
Antiviral cytokines pick up T cell slack
From the Schiffer group, Vaccine and Infectious Disease Division
Genomic surveillance of the Colombian Zika virus outbreak
From the Bedford lab, Vaccine and Infectious Disease Division
Hutch influenza experts assay the latest science
Flu shots remain your best bet for protection, but no guarantee against infection
MERS remains primarily a camel virus — for now
Fred Hutch researchers use genetic sequence data to show virus reaches ‘dead end’ in humans